Schedule 13G ownership disclosure
Adagene Inc.
Ordinary Shares · CUSIP: 005329107
Event date: 2024-12-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Panacea Venture Healthcare Fund II, L.P.
Shares: 3,037,500 · Class: 5.5%
- Panacea Venture Healthcare Fund II GP Company, Ltd.
Shares: 3,037,500 · Class: 5.5%
- Panacea Innovation Limited
Shares: 3,037,500 · Class: 5.5%
- James Huang
Shares: 3,037,500 · Class: 5.5%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000950170-25-021294
- Form type
- SCHEDULE 13G/A
- Filer
- Adagene Inc.
- CIK
- CIK 1818838
- Filed
- Feb 14, 2025
- Reporting period
- Dec 31, 2024
- Description
- Schedule 13G beneficial ownership